In this survey of oncologists, most reported that they were unable to prescribe a preferred cancer drug at least once over the previous 6 months because of a drug shortage. Some oncologists had to delay treatment or make substitutions, often with more expensive drugs.
No takes yet. Share an insight, caveat, or question.
Gogineni et al. (2013) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: